Filter
1504
Filtered Results: 1504
Text search:
Martin,
D.
et
al.
Featured
Recommendations
111
New Publications
221
Language
Document type
No document type
719
Studies & Reports
344
Guidelines
267
Manuals
82
Strategic & Response Plan
28
Fact sheets
28
Training Material
26
Brochures
4
Situation Updates
2
Resource Platforms
2
Infographics
2
Countries / Regions
Global
68
Latin America and the Carribbean
46
Western and Central Europe
43
Brazil
39
Russia
32
India
29
Germany
26
Kenya
25
Ukraine
22
Eastern Europe
21
South Africa
16
Colombia
14
Argentina
13
Senegal
12
Africa
12
Venezuela
12
Uganda
12
Rwanda
10
Burkina Faso
10
Mozambique
10
Sierra Leone
9
Haiti
9
Peru
8
West and Central Africa
8
Paraguay
8
Indonesia
8
Liberia
8
Nigeria
7
Malawi
7
Congo, Democratic Republic of
7
Ghana
6
Benin
6
Chile
6
Cameroon
6
Syria
6
Philippines
6
Angola
6
Zambia
6
Myanmar / Burma
6
Guinea
5
Eastern Europe and Central Asia
5
Spain
5
Bolivia
5
Bangladesh
5
Ethiopia
5
Zimbabwe
4
Asia
4
Guinea-Bissau
4
Tanzania
4
South–East Asia Region
4
South Sudan
4
Ecuador
4
Nepal
3
China
3
Afghanistan
3
Middle East and North Africa
3
East and Southern Africa
3
Madagascar
3
Pakistan
3
Tajikistan
2
Thailand
2
Lesotho
2
Cambodia
2
United Kingdom
2
Southern Africa
2
Papua New Guinea
2
Namibia
2
Yemen
2
Chad
2
Eswatini/ Swaziland
2
North Macedonia
1
Mexico
1
El Salvador
1
Serbia
1
Albania
1
Morocco
1
Mongolia
1
Italy
1
Armenia
1
USA
1
Dominican Republic
1
Jordan
1
North America
1
France
1
Portugal
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Vietnam
1
Moldova
1
Sri Lanka
1
Egypt
1
Central African Republic
1
Honduras
1
Mali
1
Botswana
1
Authors & Publishers
Publication Years
Category
Countries
373
Clinical Guidelines
153
Public Health
84
Women & Child Health
77
Key Resources
40
Pharmacy & Technologies
16
Capacity Building
15
Toolboxes
Mental Health
203
COVID-19
175
TB
157
HIV
117
Planetary Health
89
NTDs
66
Caregiver
56
Disability
43
Rapid Response
42
NCDs
38
Global Health Education
27
Pharmacy
26
Refugee
25
Ebola
24
AMR
24
Conflict
23
Natural Hazards
18
Health Financing Toolbox
15
Zika
14
Social Ethics
9
Polio
8
Specific Hazards
7
Cholera
6
South Sudan
1
Vaccines 2021, 9(2), 160; https://doi.org/10.3390/vaccines9020160
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face and what can be done to make them as effective as possible. With this in mind, this manual is...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
This Global Competency Standards sets the benchmark for the health workforce in providing equality of care to refugees and migrants. Refugee and migrant populations are highly diverse, with significant variation in life experiences, health needs and access to health care. The standards described out...
Consensual Recommendation for treatment of COVID-19 in older adults
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
History has shown that governments tend to deprioritize environmental commitments during times of financial and public crises as they work to mitigate immediate needs—and the age of COVID-19 has been no different. Even though human interaction with wildlife is believed to be the cause of the pande...
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
